Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Xenetic Biosciences Inc
XBIO | US
3.05
USD-0.08
-2.56%
XBIO | US
Loading StockChartView...
About Xenetic Biosciences Inc
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
24/04/2026
Close
3.05
Open
3.05
High
3.12
Low
3.05
Xenetic Biosciences Inc. a biopharmaceutical company focuses on advancing XCART a personalized chimeric antigen receptor T cell (CAR T) platform technology engineered to target patient-specific tumor neoantigens. The company engages in the development of biologic drugs and therapeutics. It advances cell-based therapeutics targeting the B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. In addition the company leveraging PolyXen its proprietary drug delivery platform by partnering with biotechnology and pharmaceutical companies. It has collaboration agreements with Takeda Pharmaceutical Co. Ltd. Serum Institute of India Limited and PJSC Pharmsynthez. Xenetic Biosciences Inc. is headquartered in Framingham Massachusetts.
View LessXBIO | US
Risk
64.1
Sharpe
0.09
Luna's Score
43/100
Recommendation
Sell
Luna says (XBIO | US)
What's Working
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
What's not Working
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
63.4%1 month
64.1%3 months
85.5%6 months
77.7%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
0.79
Debt to equity
-
Debt to assets
-
Ent. to EBITDA
1.03
Ent. to rev.
0.12
PEG
-
Other Fundamentals
EBITDA
-5.75M
MarketCap
4.70M
MarketCap(USD)
4.70M
Div. yield
-
Op. margin
-184.11
Erngs. growth
-
Rev. growth
11.60
Ret. on equity
-48.61
Short ratio
0.20
Short perc.
0.21
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
0.69
Range1M
1.03
Range3M
1.63
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.48
Price X volume
24.25K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 1.03 | 0.53 | Expensive |
| Ent. to Revenue | 0.12 | 3,967.00 | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 0.79 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 85.50 | 72.80 | Par |
| Debt to Equity | - | -1.23 | - |
| Debt to Assets | - | 0.25 | - |
| Market Cap | 4.70M | 3.66B | Emerging |
